25 LLC’s Abbott ABT Stock Holding History

25 LLC’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10	Closed	-$1.08K	–	42
2023 Q2	$1.08K	Hold	10	–	–	﹤0.01%	270
2023 Q1	$1.11K	Buy	+10	New	+$1.06K	﹤0.01%	226

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

25 LLC's ABT Position: Q3 2023 in Review

25 LLC sold out of Abbott (ABT) in Q3 2023, closing a stake of 10 shares — an estimated $1.08K sold.

25 LLC first reported a position in ABT in Q1 2023 and held it in 2 quarters. The position peaked at $1.11K in Q1 2023. 2,681 funds tracked by Wall St. Rank hold ABT as of Q3 2023.

25 LLC reported no remaining Abbott position as of Q3 2023 after selling out during the quarter.
25 LLC sold 10 Abbott shares in Q3 2023, an estimated $1.08K.
25 LLC first reported a position in Abbott in Q1 2023 and held it in 2 quarters.
25 LLC's Abbott position peaked at $1.11K in Q1 2023.
2,681 funds tracked by Wall St. Rank held Abbott as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.